Targeting CSC-related miRNAs for cancer therapy by natural agents

Bin Bao1, Yiwei Li, Aamir Ahmad

  • 1Departments of Pathology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.

Current Drug Targets
|November 13, 2012
PubMed

Insights

Cancer stem cells (CSCs) drive tumor progression and treatment resistance. MicroRNAs (miRNAs) regulate CSCs, offering potential therapeutic targets, including nutraceuticals, for improved cancer treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Stem Cell Research

Background:

  • Cancer stem cells (CSCs) are implicated in tumor metastasis and treatment resistance, leading to poor patient outcomes.
  • Understanding CSC regulation is crucial for developing effective cancer therapies.
  • MicroRNAs (miRNAs) are key post-transcriptional regulators involved in tumorigenesis and cancer progression.

Purpose of the Study:

  • To discuss the regulatory role of miRNAs in cancer stem cell phenotype and function.
  • To explore the involvement of miRNAs in tumor development and progression.
  • To investigate the potential of nutraceuticals in targeting CSC-related miRNAs for cancer therapy.

Main Methods:

  • Literature review of studies on miRNAs, CSCs, and tumorigenesis.
  • Analysis of miRNA expression patterns in various tumors.
  • Examination of specific miRNAs (e.g., let-7, miR-21, miR-34) associated with CSCs.
  • Review of research on nutraceuticals targeting CSC-related miRNAs.

Main Results:

  • Altered miRNA expression is linked to poor clinical outcomes in cancer patients.
  • Specific miRNAs (let-7, miR-21, miR-22, miR-34, miR-101, miR-146a, miR-200) are associated with CSC phenotype and function.
  • miRNAs regulate key processes including tumor cell growth, migration, invasion, angiogenesis, drug resistance, and metastasis.
  • Nutraceuticals show potential as anti-tumor agents by targeting CSC-related miRNAs.

Conclusions:

  • miRNAs play a critical role in regulating cancer stem cell phenotype and function during tumor development.
  • Targeting CSC-related miRNAs represents a promising therapeutic strategy for cancer treatment and prevention.
  • Nutraceuticals may offer a novel approach to cancer therapy by modulating CSC-related miRNAs.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...